Pillstats
Rx only · Solution · Ophthalmic

Travoprost

Travoprost

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)283809
US makers2 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.99$5.98$8.96$11.95Dec 2025Apr 2026Jul 2026
$8.210
Latest avg · Jul 22, 2026
-21%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5701.1K1.7K2.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
837
Rx · 2026 Q1
3.9K
Units dispensed
-58%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Golden State Medical Supply, Inc.unknown2SUPPLYING
Apotex Corp.unknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 25, 2023
    RECALLRecall (Class II): Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactu…

    Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container. — Recalling firm: Golden State Medical Supply Inc. — Nationwide in the USA

  • Mar 15, 2021
    RECALLRecall (Class II): TRAVOPROST OPHTHALMIC SOLUTION, USP 0.004% 2.5ML ; NDC/UPC 60505-0593-4; RX; DROPS

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC